The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy is a research paper published in Oncotarget (2023). On theSindex it has a DataRank of 0. It has been cited 26 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: 5R01AG073874-02
Investigating the role for Utrophin in age-related decline of the Merkel lineage
NIA NIH HHS
Grant: R01 AG073874
FWCI
2.41
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals